Qube Research & Technologies Ltd - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 135 filers reported holding AMNEAL PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.1%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$101,838
+62.2%
73,265
+132.2%
0.00%
Q4 2022$62,796
-64.7%
31,556
-9.3%
0.00%
-100.0%
Q2 2021$178,000
-59.1%
34,780
-46.2%
0.00%
-71.4%
Q1 2021$435,000
+353.1%
64,690
+160.3%
0.01%
+600.0%
Q3 2020$96,000
-83.9%
24,852
-80.2%
0.00%
-88.9%
Q2 2020$598,000
+203.6%
125,584
+207.4%
0.01%
+50.0%
Q4 2019$197,00040,8510.01%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$83,503,0007.34%
Eversept Partners, LP 2,656,208$10,306,0872.29%
TPG Group Holdings (SBS) Advisors, Inc. 16,213,367$62,908,0001.13%
Prosight Management, LP 512,659$1,989,0000.95%
THB ASSET MANAGEMENT 833,104$3,232,0000.90%
GLOBEFLEX CAPITAL L P 251,696$977,0000.26%
XTX MARKETS LLC 10,243$40,0000.19%
HUSSMAN STRATEGIC ADVISORS, INC. 102,000$396,0000.10%
PA Capital LLC 33,874$132,0000.09%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 60,900$236,0000.07%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders